These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19956878)

  • 41. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of cannabinoid CB1 receptors in improgan antinociception.
    Gehani NC; Nalwalk JW; Razdan RK; Martin BR; Sun X; Wentland M; Abood ME; Hough LB
    J Pain; 2007 Nov; 8(11):850-60. PubMed ID: 17644043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [II. Postoperative adjuvant chemotherapy for colon cancer. 1. Is oxaliplatin combination the most effective chemotherapy for colon cancer?].
    Sato T; Nakamura T; Naitou M; Ogura N; Miura H; Tsutsui A; Watanabe M
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1642-. PubMed ID: 23243701
    [No Abstract]   [Full Text] [Related]  

  • 44. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
    Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
    J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
    López-Moreno JA; González-Cuevas G; Navarro M
    Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.
    Gustafsson SB; Lindgren T; Jonsson M; Jacobsson SO
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):691-701. PubMed ID: 18629502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways.
    Gallotta D; Nigro P; Cotugno R; Gazzerro P; Bifulco M; Belisario MA
    Biochem Pharmacol; 2010 Aug; 80(3):370-80. PubMed ID: 20417624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice.
    Liu YL; Connoley IP; Wilson CA; Stock MJ
    Int J Obes (Lond); 2005 Feb; 29(2):183-7. PubMed ID: 15558076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.
    Kumar Srivastava B; Soni R; Patel JZ; Jha S; Shedage SA; Gandhi N; Sairam KV; Pawar V; Sadhwani N; Mitra P; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3882-6. PubMed ID: 18585913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine.
    Hector S; Tummala R; Kisiel ND; Diegelman P; Vujcic S; Clark K; Fakih M; Kramer DL; Porter CW; Pendyala L
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):517-27. PubMed ID: 17987291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
    Wright KL; Robertson DA; Moyer MP; Ward SG
    Int J Cancer; 2008 Apr; 122(8):1920-1. PubMed ID: 18076045
    [No Abstract]   [Full Text] [Related]  

  • 52. Oxaliplatin in colon cancer.
    Mandalà M; Ferretti G; Barni S
    N Engl J Med; 2004 Oct; 351(16):1691-2; author reply 1691-2. PubMed ID: 15483293
    [No Abstract]   [Full Text] [Related]  

  • 53. Targeting of cancer‑associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment.
    Li M; Li M; Yin T; Shi H; Wen Y; Zhang B; Chen M; Xu G; Ren K; Wei Y
    Mol Med Rep; 2016 Mar; 13(3):2476-84. PubMed ID: 26846566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression.
    Li W; Xu J; Zhao J; Zhang R
    Med Sci Monit; 2017 Feb; 23():780-789. PubMed ID: 28190020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells.
    Khosrawipour V; Diaz-Carballo D; Acikelli AH; Khosrawipour T; Falkenstein TA; Wu D; Zieren J; Giger-Pabst U
    World J Surg Oncol; 2017 Feb; 15(1):43. PubMed ID: 28183319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment.
    Proto MC; Fiore D; Bifulco M; Gazzerro P
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges.
    Saleemi MA; Yahaya N; Zain NNM; Raoov M; Yong YK; Noor NS; Lim V
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.
    Iozzo M; Sgrignani G; Comito G; Chiarugi P; Giannoni E
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards an Improvement of Anticancer Activity of Benzyl Adenosine Analogs.
    Covelli V; Grimaldi M; Randino R; Firoznezhad M; Proto MC; Simone V; Matteoli G; Gazzerro P; Bifulco M; D'Ursi AM; Rodriquez M
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabinoids in the landscape of cancer.
    Mangal N; Erridge S; Habib N; Sadanandam A; Reebye V; Sodergren MH
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2507-2534. PubMed ID: 34259916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.